ISN 9.09% 6.0¢ isonea limited

Agree. $4 is nothing to evaluate what could develop into a...

  1. 7,746 Posts.
    Agree. $4 is nothing to evaluate what could develop into a market leading asthma monitoring device/app. What will set us apart is being able to collate the data recorded by users, then using cloud technology, store and transmit the data to QUALIFIED physicians.

    So it becomes more than just being reliant on a number. An actual physician will be able to determine erronous inputs. And analyse the data in context of months of data to correctly manage and improve the well being of asthmatics.
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.